PTHS Insider Trading Activity and SEC Form 4 Filings
PTHS insider trading summary
Over the past 12 months, insiders at Pelthos Therapeutics Inc. (PTHS) reported 24 sales worth $486K by 5 insiders and 2 open-market purchases worth $1000K by 1 insider on SEC Form 4. Net insider buying was $514K.
Latest PTHS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Matthew Pauls | Director | Sell | $17K (786 @ $21.00) |
| Oct 2, 2026 | Peter Greenleaf | Director | Sell | $17K (797 @ $21.17) |
| Oct 2, 2026 | Ezra M Friedberg | Director | Sell | $12K (558 @ $20.72) |
| Jul 2, 2026 | Peter Greenleaf | Director | Sell | $2K (85 @ $27.27) |
| Jul 2, 2026 | Matthew Pauls | Director | Sell | $3K (94 @ $27.36) |
| Jul 2, 2026 | Peter Greenleaf | Director | Sell | $19K (712 @ $26.00) |
| Jul 2, 2026 | Ezra M Friedberg | Director | Sell | $656 (24 @ $27.33) |
| Jul 2, 2026 | Matthew Pauls | Director | Sell | $18K (692 @ $26.00) |
| Jul 2, 2026 | Ezra M Friedberg | Director | Sell | $14K (534 @ $26.03) |
| Jun 15, 2026 | Ezra M Friedberg | Director | Sell | $6K (224 @ $27.12) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.